Loading data for OSRH — first visit, this takes a few seconds.
OSR Health Inc. (OSRH)
NasdaqCM: OSRH
· Precio en tiempo real · USD
0.39
-0.04 (-9.30%)
Al cierre: Aug 19, 2026, 9:39 AM
OSR Health Inc. (OSRH) Stock Price, Analysis & Data
-9.30% (1D)
| Precio de compra | 0.35 |
| Capitalización de mercado | 13.69M |
| Ingresos (TTM) | 1.81M |
| Beneficio neto (TTM) | -10.73M |
| Beta | n/a |
| EPS (TTM) | 0.03 |
| Ratio PER (TTM) | 12.99 |
| Adelante PE | n/a |
| P/B (TTM) | 0.12 |
| P/S (TTM) | 7.57 |
| Earnings Date | n/a |
| Precio de venta | 0.5 |
| Volumen | 17,545,270 |
| Volumen medio (20D) | 9,156,301 |
| Abierto | 0.42 |
| Anterior Cerrar | 0.43 |
| Rango del día | 0.38 - 0.51 |
| Rango de 52 semanas | 0.25 - 1.24 |
| analista | n/a |
| Precio objetivo | n/a |
| Dividendos | n/a |
| Fecha ex dividendo | n/a |
Acerca de OSRH
OSR Health, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Europe, and Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma completed phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatment of Wilms Tumor Protein (WT1); VXM08 for Carcinoembryonic antig...
Industria Biotechnology
Sector Healthcare
IPO Fecha Mar 21, 2023
Empleados 22
Bolsa de Valores NasdaqCM
Símbolo bursátil OSRH
Sitio web https://osr-holdings.com
Desempeño financiero
En 2025, los ingresos de OSR Health fueron 2.91M, una disminución de -17.69% en comparación con 3.53M del año anterior. Las ganancias fueron -18.01M, un aumento de 74.37%.
Estados financierosSorpresa de resultados
OSR Health ha publicado sus resultados trimestrales en Mar 31, 2026:
